|1.||Davis, C Ainsley: 4 articles (11/2004 - 07/2003)|
|2.||Barber, Michael J: 4 articles (11/2004 - 07/2003)|
|3.||Trepanier, Lauren A: 3 articles (10/2012 - 01/2010)|
|4.||Sacco, James C: 3 articles (10/2012 - 01/2010)|
|5.||Frei, Eva: 2 articles (01/2015 - 01/2011)|
|6.||Abouraya, Mahmoud: 2 articles (10/2012 - 02/2012)|
|7.||Naraharisetti, Suresh Babu: 2 articles (09/2009 - 08/2008)|
|8.||Aggarwal, Manoj: 2 articles (09/2009 - 08/2008)|
|9.||Barber, M J: 2 articles (01/2006 - 06/2005)|
|10.||Crowley, L J: 2 articles (01/2006 - 06/2005)|
07/01/2008 - "Cytochrome b5 expression in gonadectomy-induced adrenocortical neoplasms of the domestic ferret (Mustela putorius furo)."
12/01/1983 - "The turnover of P-450 was not affected by the tumor, whereas cytochrome b5 turnover was decreased. "
01/01/1987 - "These tumors showed a marked decrease in cytochrome P-450 (53%), cytochrome b5 (79%) and aryl hydrocarbon hydroxylase (55%) activities compared to normal livers. "
07/01/2008 - "We screened ferret adrenocortical tumor specimens for expression of cytochrome b(5) (cyt b(5)), an allosteric regulator that selectively enhances the 17,20-lyase activity of P450c17. "
03/01/1997 - "Concentrations of P450 total content, cytochrome b5, and NADPH-cytochrome c reductase showed parallel and marked reduction in tumor tissues when compared with its distant normal regions or normal livers. "
|2.||Sarcoma (Soft Tissue Sarcoma)
01/01/2010 - "Reduction in tumor weight was noted in Group III as compared to II. The levels of cytochrome C in liver and kidney, the levels of cytochrome P450 and cytochrome b5 in liver microsomes, phase I biotransformation enzymes NADPH-cytochrome P450, NADPH-cytochrome b5, and aniline hydroxylase, and the phase II enzymes glutathione-S-transferase and UDP glucuronyl transferase indicated that their modulation played a role in the therapeutic efficacy of Indigofera aspalathoides against experimental fibrosarcoma."
05/15/2004 - "Cytochrome b5 oxidoreductase: expression and characterization of the original familial ideopathic methemoglobinemia mutations E255- and G291D."
05/01/1994 - "A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism."
10/02/1986 - "Congenital methemoglobinemia with cytochrome b5 deficiency."
03/20/1986 - "Congenital methemoglobinemia with a deficiency of cytochrome b5."
01/01/1986 - "Type II, generalized cytochrome B5 deficiency demonstrable in all of the tissues that have been examined, is accompanied by severe, lethal, progressive neurological disability, in addition to methemoglobinemia. "
12/01/2015 - "In this study, in order to investigate how cytochrome b5 reductase (b5R), one of the PM redox enzymes, regulates cellular response under stressed conditions, human neuroblastoma cells transfected with b5R were used for viability and mitochondrial functional assays. "
01/01/2011 - "Based on these studies, we attribute most of the enhancing effects of VPA and TSA on ellipticine cytotoxicity to enhanced ellipticine-DNA adduct formation caused by an increase in levels of cytochrome b5, CYP3A4 and CYP1A1 in neuroblastoma cells. "
01/01/2011 - "The effects of ellipticine in the presence of VPA and TSA on expression of CYPs and peroxidases relevant for ellipticine activation and levels of cytochrome b5 and P-glycoprotein in neuroblastoma cells were also investigated. "
|1.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|4.||NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)
|5.||Glutathione Transferase (Glutathione S-Transferase)
|6.||Cytochrome-B(5) Reductase (Methemoglobin Reductase)
|7.||Cytochromes c (Cytochrome c)
|8.||Glucuronosyltransferase (UDP Glucuronosyltransferase)
|1.||Transplantation (Transplant Recipients)